Price$4.78+0.14 (+3.02%)
01:30 PM07:45 PM
News · 26 weeks71-62%
2025-12-142026-06-07
Mix2390d
- Other7(30%)
- Insider6(26%)
- SEC Filings5(22%)
- Leadership3(13%)
- Earnings2(9%)
Latest news
25 items- INSIDERDeputy General Counsel Caezza Nicholas sold $7,831 worth of shares (1,733 units at $4.52), decreasing direct ownership by 0.56% to 310,307 units (SEC Form 4) to satisfy tax liability4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Neubauer Caroll H was granted 73,170 shares (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERSEC Form 3 filed by new insider Neubauer Caroll H3 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRButterfly Network to Participate in the William Blair 46th Annual Growth Stock ConferenceThe Company presentation will occur at 8:40 AM CT on Thursday, June 4, 2026 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), today announced that the company will participate at the William Blair 46th Annual Growth Stock Conference. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer will participate in a presentation breakout session at 8:40 AM CT on June 4, 2026, and host one-on-one investor meetings throughout the day. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations). To schedule a one-on-one meet
- PRCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsIssued on behalf of Ventripoint Diagnostics Ltd.A Toronto-based small-cap is converting clinical validation into real-world hospital deployments at the moment AI cardiac imaging procurement is reorganizing globallyNEW YORK, May 19, 2026 /CNW/ -- USA News Group News Commentary — Cardiology has become one of the proving grounds for medical artificial intelligence, and the procurement environment around it has shifted hard in the last twelve months. Hospital networks are no longer content to evaluate clinical accuracy in isolation; they want department-level economic proof before they sign deployment contracts. That shift is reshaping which AI imaging companies can convert pilot data into recur
- PRA Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechVMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The AI-cardiac-diagnostics category is one of the more measurable inflection points in the broader medtech sector heading into the second half of 2026. The global AI cardiology market is projected to reach approximately US$2.78 billion in 2026 and climb past US$14 billion by 2034 as software-based diagnostics replace hardware-based imaging across an aging patient base and a healthcare system increasingly cost-pressured at
- PRThe Future of Intoxication Detection May Be in Your VoiceAUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to healthcare and public health management. Traditional methods such as breathalyzers, blood tests and urine screenings are often limited by their invasiveness, delayed results or inability to assess real-time impairment, particularly in cases involving multiple substances. As patterns of substance use evolve and the societal costs of impaired behavior continue to rise, the demand for faster, more scalable and noninvasive diagnostic solutions is becoming
- SECButterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Butterfly Network, Inc. (0001804176) (Filer)
- PRButterfly Network Appoints Caroll H. Neubauer to Board of DirectorsSeasoned Medtech Leader and Former Chairman and CEO of B. Braun of America Brings Deep Healthcare Industry Expertise Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board's Compensation Committee and Technology Committee. Mr. Neubauer has achieved a distinguished career spanning three decades with B. Braun, including serving for 29 years on the Global Management Board of the B. Braun Group of Companies. During his tenure, he helped grow annual revenue
- PRButterfly Network to Present at the Bank of America Securities 2026 Global Healthcare ConferenceThe Company presentation will occur at 4:35 PM PT on Tuesday, May 12, 2026 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), today announced that the company will participate at the Bank of America Securities 2026 Global Healthcare Conference. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer will present at 4:35 PM PT on May 12, 2026, and host one-on-one investor meetings throughout the day. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations). To schedule a one-on-one meeting with Butterfly management
- INSIDERCAO and SVP, Finance Carlson Megan sold $524,394 worth of shares (110,422 units at $4.75), decreasing direct ownership by 18% to 507,209 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERChief Business Officer Cashman Steve sold $724,166 worth of shares (147,518 units at $4.91), decreasing direct ownership by 7% to 2,029,868 units (SEC Form 4) (tax liability)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECSEC Form 10-Q filed by Butterfly Network Inc.10-Q - Butterfly Network, Inc. (0001804176) (Filer)
- SECButterfly Network Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Butterfly Network, Inc. (0001804176) (Filer)
- PRButterfly Network Reports First Quarter 2026 Financial ResultsDelivered Revenue Above Consensus and Beat Adjusted EBITDA Guidance Reaffirmed full year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $26.5 million in Q1, representing 25% YoY growth Delivered 69% Gross Margin up 600 bps and Adjusted EBITDA of ($6.1M) up 32% YoY Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the first quarter ended March 31, 2026, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "Butterfly opened the year with ano
- SECSEC Form DEFA14A filed by Butterfly Network Inc.DEFA14A - Butterfly Network, Inc. (0001804176) (Filer)
- SECSEC Form DEF 14A filed by Butterfly Network Inc.DEF 14A - Butterfly Network, Inc. (0001804176) (Filer)
- PRButterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUSProminent POCUS thought leader joins to advance clinical strategy and further Butterfly's mission to democratize ultrasound worldwide. Butterfly Network (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company's core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts. Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, educ
- INSIDERSEC Form 4 filed by Cashman Steve4 - Butterfly Network, Inc. (0001804176) (Issuer)
- PRButterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report first quarter 2026 financial results on Thursday, April 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on April 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.
- PRButterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's HealthThe new AI-powered tool determines how far along a pregnancy is in minutes—providing critical information to guide timely care and help reduce maternal and fetal mortality worldwide. Butterfly Network, Inc. ("Butterfly," "the Company") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated Gestational Age (GA) Tool integrated into its handheld ultrasound solution. This marks the first FDA-cleared blind-sweep ultrasound AI tool for estimating gestational age. This press release features multimedia. View the full release
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Butterfly Network Inc.SCHEDULE 13G/A - Butterfly Network, Inc. (0001804176) (Subject)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
- PRButterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic
- INSIDERPresident & CEO Devivo Joseph sold $1,788,291 worth of shares (482,149 units at $3.71), decreasing direct ownership by 6% to 8,030,899 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
BFLY FAQ
7 questionsWhat does Butterfly Network Inc. do?
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.Where does BFLY stock trade?
Butterfly Network Inc. (BFLY) is listed on NYSE.What sector and industry is BFLY in?
Butterfly Network Inc. operates in the Health Care sector, Medical Electronics industry.When did Butterfly Network Inc. go public?
Butterfly Network Inc. (BFLY) completed its IPO in 2020.What are analysts saying about BFLY?
Butterfly Network Inc. has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Perform on 2025-08-01. Recent price targets range from $225.00 to $950.00.What companies are similar to BFLY?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare BFLY side-by-side with any of them on Quantisnow.How can I track BFLY on Quantisnow?
Quantisnow aggregates Butterfly Network Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BFLY to receive live email and push alerts on every new disclosure.